Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biological Specimen Banks | 4 | 2022 | 56 | 1.040 |
Why?
|
| Tetralogy of Fallot | 2 | 2025 | 176 | 0.830 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2025 | 174 | 0.830 |
Why?
|
| Stroke Volume | 1 | 2025 | 538 | 0.750 |
Why?
|
| Ventricular Function, Left | 1 | 2025 | 547 | 0.700 |
Why?
|
| Retinoblastoma | 3 | 2012 | 112 | 0.680 |
Why?
|
| Echocardiography | 1 | 2025 | 1128 | 0.610 |
Why?
|
| Biomedical Research | 3 | 2020 | 553 | 0.570 |
Why?
|
| Oncolytic Viruses | 3 | 2013 | 76 | 0.430 |
Why?
|
| Retinal Neoplasms | 2 | 2012 | 101 | 0.430 |
Why?
|
| Heart Septal Defects | 2 | 2025 | 44 | 0.400 |
Why?
|
| Picornaviridae | 2 | 2013 | 21 | 0.380 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2012 | 86 | 0.370 |
Why?
|
| Antigens, CD | 1 | 2012 | 431 | 0.330 |
Why?
|
| Glycoproteins | 1 | 2012 | 375 | 0.320 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 633 | 0.300 |
Why?
|
| Retina | 1 | 2012 | 490 | 0.290 |
Why?
|
| Peptides | 1 | 2012 | 846 | 0.290 |
Why?
|
| Mitral Valve Stenosis | 1 | 2025 | 39 | 0.230 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 212 | 0.220 |
Why?
|
| Genetic Therapy | 1 | 2007 | 719 | 0.200 |
Why?
|
| Public Opinion | 1 | 2022 | 62 | 0.190 |
Why?
|
| Reoperation | 1 | 2025 | 851 | 0.180 |
Why?
|
| Receptor, Notch4 | 1 | 2020 | 5 | 0.170 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 1829 | 0.170 |
Why?
|
| Oncolytic Virotherapy | 2 | 2013 | 89 | 0.170 |
Why?
|
| Bacillus | 1 | 2000 | 37 | 0.170 |
Why?
|
| Repressor Proteins | 2 | 2016 | 812 | 0.160 |
Why?
|
| Research Personnel | 1 | 2020 | 136 | 0.150 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 282 | 0.150 |
Why?
|
| Neoplasm Transplantation | 2 | 2011 | 382 | 0.150 |
Why?
|
| Progesterone | 1 | 2000 | 451 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 401 | 0.140 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2022 | 271 | 0.140 |
Why?
|
| Heart Defects, Congenital | 2 | 2022 | 1861 | 0.140 |
Why?
|
| Down Syndrome | 1 | 2020 | 230 | 0.140 |
Why?
|
| Brain Neoplasms | 3 | 2013 | 1378 | 0.130 |
Why?
|
| Child | 6 | 2025 | 25761 | 0.130 |
Why?
|
| Proteomics | 1 | 2020 | 596 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 684 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2025 | 1173 | 0.120 |
Why?
|
| RNA Splicing Factors | 1 | 2016 | 53 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 32 | 0.120 |
Why?
|
| Quality Control | 1 | 2016 | 123 | 0.120 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 144 | 0.120 |
Why?
|
| Specimen Handling | 1 | 2016 | 149 | 0.120 |
Why?
|
| Infant | 3 | 2025 | 13047 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2022 | 657 | 0.110 |
Why?
|
| Humans | 20 | 2025 | 131924 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2016 | 363 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 1044 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2025 | 3139 | 0.100 |
Why?
|
| PAX6 Transcription Factor | 1 | 2012 | 38 | 0.100 |
Why?
|
| AC133 Antigen | 1 | 2012 | 37 | 0.100 |
Why?
|
| Genomics | 1 | 2020 | 1647 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2016 | 2674 | 0.090 |
Why?
|
| Phenotype | 1 | 2022 | 4526 | 0.090 |
Why?
|
| Paired Box Transcription Factors | 1 | 2012 | 75 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2025 | 14732 | 0.090 |
Why?
|
| Immunophenotyping | 1 | 2012 | 343 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 4680 | 0.090 |
Why?
|
| Eye Proteins | 1 | 2012 | 232 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2012 | 791 | 0.080 |
Why?
|
| Blood-Brain Barrier | 1 | 2010 | 156 | 0.080 |
Why?
|
| Stem Cells | 1 | 2014 | 732 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 574 | 0.070 |
Why?
|
| Mice | 6 | 2013 | 18460 | 0.070 |
Why?
|
| Glioma | 1 | 2013 | 529 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2010 | 347 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 90 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 763 | 0.070 |
Why?
|
| Hyaluronan Receptors | 1 | 2006 | 62 | 0.060 |
Why?
|
| Female | 8 | 2025 | 70584 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 2443 | 0.060 |
Why?
|
| Cystadenoma, Serous | 1 | 2005 | 7 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 293 | 0.060 |
Why?
|
| Azetidines | 1 | 2006 | 64 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2006 | 108 | 0.060 |
Why?
|
| Medulloblastoma | 1 | 2010 | 570 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2005 | 57 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 663 | 0.060 |
Why?
|
| Male | 4 | 2025 | 64870 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3351 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 351 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 719 | 0.060 |
Why?
|
| Animals | 6 | 2013 | 34781 | 0.060 |
Why?
|
| Phyllodes Tumor | 1 | 2004 | 9 | 0.060 |
Why?
|
| Vaginal Neoplasms | 1 | 2004 | 18 | 0.050 |
Why?
|
| Myxoma | 1 | 2004 | 28 | 0.050 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2004 | 63 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2006 | 595 | 0.050 |
Why?
|
| Leiomyosarcoma | 1 | 2004 | 28 | 0.050 |
Why?
|
| Trimethylsilyl Compounds | 1 | 2003 | 2 | 0.050 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2003 | 40 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2003 | 67 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2025 | 12991 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2005 | 367 | 0.050 |
Why?
|
| Peritoneal Neoplasms | 1 | 2004 | 57 | 0.050 |
Why?
|
| Uterine Neoplasms | 1 | 2004 | 110 | 0.050 |
Why?
|
| Image Cytometry | 1 | 2022 | 11 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2022 | 11 | 0.050 |
Why?
|
| Steroids | 1 | 2003 | 173 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 247 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2005 | 462 | 0.040 |
Why?
|
| Androstenedione | 1 | 2000 | 15 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 1 | 2000 | 44 | 0.040 |
Why?
|
| Biotransformation | 1 | 2000 | 56 | 0.040 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 156 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2013 | 601 | 0.040 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 217 | 0.040 |
Why?
|
| Monocytes | 1 | 2022 | 340 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 381 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2000 | 322 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 337 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 224 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5163 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 346 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2013 | 990 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 327 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 147 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 761 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 1015 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2022 | 861 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 1304 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2022 | 698 | 0.030 |
Why?
|
| Glucose | 1 | 2000 | 870 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2221 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2025 | 3732 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 777 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8542 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 412 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 6440 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 234 | 0.030 |
Why?
|
| Cell Communication | 1 | 2014 | 186 | 0.030 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2013 | 28 | 0.030 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 154 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1095 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 768 | 0.020 |
Why?
|
| Troponin T | 1 | 2014 | 295 | 0.020 |
Why?
|
| Adult | 4 | 2025 | 31536 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 2645 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2016 | 784 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 9952 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 271 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 10933 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 2140 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 249 | 0.020 |
Why?
|
| Adolescent | 2 | 2025 | 20535 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2022 | 4703 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2696 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1572 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1077 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1284 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 17374 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1960 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2850 | 0.020 |
Why?
|
| Ezetimibe | 1 | 2006 | 94 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 2186 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 2005 | 124 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2005 | 195 | 0.010 |
Why?
|
| Mastectomy, Simple | 1 | 2004 | 2 | 0.010 |
Why?
|
| United States | 1 | 2020 | 11648 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 588 | 0.010 |
Why?
|
| Omentum | 1 | 2004 | 47 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 1891 | 0.010 |
Why?
|
| Hydroxylation | 1 | 2003 | 51 | 0.010 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2003 | 30 | 0.010 |
Why?
|
| Calibration | 1 | 2003 | 99 | 0.010 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2004 | 65 | 0.010 |
Why?
|
| Catalysis | 1 | 2003 | 139 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 1978 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 3678 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2006 | 925 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2004 | 231 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 2718 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2006 | 803 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 635 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1347 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2004 | 986 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 3011 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 4751 | 0.010 |
Why?
|
| Middle Aged | 2 | 2005 | 28943 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 6226 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 7543 | 0.010 |
Why?
|